1. Home
  2. GROW vs MRNS Comparison

GROW vs MRNS Comparison

Compare GROW & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GROW
  • MRNS
  • Stock Information
  • Founded
  • GROW 1968
  • MRNS 2003
  • Country
  • GROW United States
  • MRNS United States
  • Employees
  • GROW N/A
  • MRNS N/A
  • Industry
  • GROW Investment Managers
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GROW Finance
  • MRNS Health Care
  • Exchange
  • GROW Nasdaq
  • MRNS Nasdaq
  • Market Cap
  • GROW 32.9M
  • MRNS 29.9M
  • IPO Year
  • GROW N/A
  • MRNS 2014
  • Fundamental
  • Price
  • GROW $2.46
  • MRNS $0.55
  • Analyst Decision
  • GROW
  • MRNS Buy
  • Analyst Count
  • GROW 0
  • MRNS 12
  • Target Price
  • GROW N/A
  • MRNS $4.28
  • AVG Volume (30 Days)
  • GROW 30.9K
  • MRNS 1.4M
  • Earning Date
  • GROW 02-12-2025
  • MRNS 03-04-2025
  • Dividend Yield
  • GROW 3.67%
  • MRNS N/A
  • EPS Growth
  • GROW N/A
  • MRNS N/A
  • EPS
  • GROW 0.12
  • MRNS N/A
  • Revenue
  • GROW $10,008,000.00
  • MRNS $31,466,000.00
  • Revenue This Year
  • GROW N/A
  • MRNS $14.97
  • Revenue Next Year
  • GROW N/A
  • MRNS $57.65
  • P/E Ratio
  • GROW $20.22
  • MRNS N/A
  • Revenue Growth
  • GROW N/A
  • MRNS 1.63
  • 52 Week Low
  • GROW $2.38
  • MRNS $0.22
  • 52 Week High
  • GROW $2.95
  • MRNS $10.50
  • Technical
  • Relative Strength Index (RSI)
  • GROW 54.17
  • MRNS 70.09
  • Support Level
  • GROW $2.43
  • MRNS $0.54
  • Resistance Level
  • GROW $2.48
  • MRNS $0.55
  • Average True Range (ATR)
  • GROW 0.04
  • MRNS 0.01
  • MACD
  • GROW 0.00
  • MRNS -0.01
  • Stochastic Oscillator
  • GROW 60.00
  • MRNS 93.00

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: